Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Hedge funds sold Moderna, BioNtech shares before vaccine news

Stock Markets Nov 18, 2020 10:45PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Moderna's logo is reflected in a drop on a syringe needle in this illustration

By Svea Herbst-Bayliss

BOSTON (Reuters) - A number of hedge funds sold positions in two drug companies leading the race to a coronavirus vaccine in the quarter before both announced breakthroughs that lifted their stock prices, while a few took stakes in the companies during that time.

Regulatory filings show that hedge funds sold millions of shares in drugmakers Moderna (NASDAQ:MRNA) and BioNtech during the third quarter, missing out on big gains this month when each announced their vaccines are more than 94% effective.

Since the end of the third quarter BioNtech's stock has jumped another 26% and Moderna's stock has climbed 28%, adding to triple-digit percentage gains and putting them among the biggest winners this year, during which the S&P 500 has rebounded 60% from its March lows.

By the end of September, Balyasny Asset Management, Adage Capital Partners and Verition Fund Management had liquidated their positions in Moderna while Healthcor Management, Logos Global Management and Duquesne Family Office exited positions in BioNtech, according to regulatory filings and data from research firm Symmetric.io.

Redmile Group, BioNtech's largest hedge fund investor, slashed its holdings by 59% during the quarter and Theleme Partners, Moderna's largest hedge fund investor, cut its exposure by 11%, regulatory filings show.

Additionally, Millennium Management, Myriad Asset Management and Citadel cut holdings in Moderna while Citadel, Balyasny and Schonfeld Strategic Advisors cut holdings in BioNtech, the filings show.

Symmetric.io data show that hedge funds owned 3.4 million shares of BioNtech, a German company which partnered with Pfizer (NYSE:PFE) to bring its vaccine to market, at the end of the quarter, 1.9 million shares less than at the start of the quarter. At Moderna, hedge funds owned 11.7 million shares at the end of the quarter, down 2.2 million shares from the start.

Moderna's stock price surged 376% since January while BioNtech's rose 157%, handily beating the S&P 500 index which is up 12%, having bounced back from deep losses earlier in 2020.

Representatives for the funds either declined to comment or did not respond to requests for comment on what prompted their sales. Investors who put money into hedge funds, including some of those mentioned in the article, said some fund managers had started locking in profits ahead of U.S. elections on worries over potential market volatility stemming from the Nov. 3 vote.

The average hedge fund gained 1.2% through October, while healthcare focused funds, on average, rose 13%, Hedge Fund Research data show.

Even as certain hedge funds took money away from Moderna and BioNtech the two companies did attract new hedge fund investors during the quarter, the data show.

Voloridge Investment Management and LMR Partners initiated new positions in Moderna while Armistice Capital and Adage Capital put on new positions in BioNtech. And Millennium boosted its investment in BioNtech while D.E.Shaw increased its holding in Moderna, the filings show.

Hedge funds sold Moderna, BioNtech shares before vaccine news
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (3)
TL Chan
TL Chan Nov 18, 2020 11:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyway, most vaccines companies are corrupted by Democrats!
Don Getty
Don Getty Nov 18, 2020 11:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
funny it was tantrum trump who has been the one tweeting and manipulating the markets for the last 4 years!
TL Chan
TL Chan Nov 18, 2020 11:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if you knew PFE is corrupted to the Biden gang, you know when to buy BNTX.
Jstvff Heng
Jstvff Heng Nov 18, 2020 10:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
damn
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email